Shankar Musunuri sold $525K of Ocugen (OCGN)

Executed Sep 9, disclosed Sep 12, 2 days later.

Value, as filed

$525K

468,727 sh × $1.12

Executed

Sep 9

the trade date, as filed

Disclosed

Sep 12

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

SM Shankar Musunuri Chief Executive Officer profile →

Shankar Musunuri (Chief Executive Officer) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Ocugen, Inc. (OCGN). The largest single filing was $525K of OCGN (468,727 sh × $1.12, as filed), executed Sep 9.

The name

OCGN Ocugen, Inc. OCGN · Healthcare · 1 filing in 24 months ticker →

Healthcare · Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic,…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→